These results suggested a potentially oncogenic role of GLRX3. However, further investigation is needed to understand the role of CAPN1 and GLRX3 in the pathogenesis of lung adenocarcinoma and the biological mechanisms of the association between the genetic variants and clinical outcomes. Here, GLRX3 is linked to lung adenocarcinoma.